Table III.
Comparison of Montreal cognitive assessment score between treatment groups of diabetic nephropathy with SCI.
| Groups | Treatment | Visuospatial/executive ability | Naming | Attention | Calculation | Language | Abstraction | Memory | Orientation | Comprehensive score |
|---|---|---|---|---|---|---|---|---|---|---|
| A (n=50) | Pretherapy | 3.20±0.26 | 2.21±0.19 | 3.15±0.27 | 2.12±0.23 | 1.29±0.10 | 1.11±0.06 | 3.11±0.36 | 4.26±0.17 | 21.80±0.69 |
| Post-treatment | 4.20±0.21b | 2.31±0.15 | 4.35±0.22b | 2.28±0.11 | 1.41±0.13 | 1.22±0.11 | 3.27±0.22 | 4.40±0.15 | 24.06±0.72b | |
| B (n=50) | Pretherapy | 3.21±0.40 | 2.20±0.18 | 3.13±0.32 | 2.13±0.28 | 1.28±0.15 | 1.10±0.05 | 3.10±0.35 | 4.26±0.15 | 21.78±0.92 |
| Post-treatment | 4.48±0.20a,b | 2.35±0.16 | 4.43±0.28a,b | 2.34±0.10 | 1.46±0.16 | 1.24±0.13 | 3.38±0.18 | 4.45±0.12 | 25.02±0.66a,b |
Values are given as mean ± standard deviation or number.
a
P<0.05, group A vs. group B
b
P<0.05, pretherapy vs. post-treatment. SCI, silent cerebral infarction.